Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial.

Nature medicine·2025
Same author

Caring for Transplanted Children and Their Families.

Transplantation and cellular therapy·2023
Same author

Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.

The New England journal of medicine·2022
Same author

Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2017
Same author

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2016
Same author

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2015

Related Experiment Video

Updated: May 9, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

A 2-hit model for chronic GVHD.

Robertson Parkman1

  • 1Children's Hospital Los Angeles.

Blood
|August 3, 2013
PubMed
Summary
This summary is machine-generated.

Acute graft-versus-host disease (GVHD) reduces critical thymic cells and self-antigen diversity. Treatment with fibroblast growth factor 7 (Fgf7) reversed these effects, offering a potential therapeutic strategy.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Area of Science:

  • Immunology
  • Transplantation Biology
  • Thymic Epithelial Cell Biology

Background:

  • Graft-versus-host disease (GVHD) is a major complication following allogeneic stem cell transplantation.
  • Medullary thymic epithelial cells (mTECs) expressing autoimmune regulator (Aire) are crucial for establishing central self-tolerance.
  • Aire-dependent tissue-restricted antigens (TRAs) presented by mTECs induce deletion of autoreactive T cells.

Purpose of the Study:

  • To investigate the impact of acute GVHD on Aire-positive mTECs and TRA diversity in mice.
  • To evaluate the therapeutic potential of fibroblast growth factor 7 (Fgf7) in mitigating GVHD-induced thymic abnormalities.

Main Methods:

  • Induction of acute GVHD in a mouse model.
  • Flow cytometry analysis of thymic populations, specifically Aire-expressing mTECs.
  • Assessment of TRA expression diversity in the thymus.

Main Results:

  • Acute GVHD led to a significant reduction in Aire-expressing mTECs.
  • GVHD also decreased the diversity of Aire-dependent TRAs in the thymus.
  • Peritransplant administration of Fgf7 reversed both the reduction in Aire+ mTECs and the loss of TRA diversity.

Conclusions:

  • Acute GVHD severely impairs thymic self-tolerance mechanisms by depleting Aire+ mTECs and reducing TRA diversity.
  • Fgf7 acts as an epithelial protectant, restoring thymic function and potentially ameliorating GVHD-related autoimmunity.
  • Fgf7 represents a promising therapeutic agent for preventing or treating GVHD-induced immune dysregulation.